Related Experiment Video
Updated: Apr 8, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
Prescribing and practice development decision-making in Irish general practices
1School of Economics, University College Cork, Cork, Ireland, jane.bourke@ucc.ie.
Background:
In Ireland, primary care is considered the appropriate setting to meet the majority of health and personal social service needs, with GPs central to its provision. Irish general practices are characterised by considerable autonomy in terms of commercial practice and the range of medical services they provide; however, little is known about what influences their decision-making with respect to the adoption of new health-care technologies.
Aim:
The aim of this paper is to provide a holistic overview on prescribing and practice development decision-making in Irish general practices.
Methods:
A summary of recent publications examining the factors influencing the adoption of new drugs, medical equipment and information and communications technology (ICT) by Irish GPs is undertaken.
Results:
These studies identify experiential learning, connectedness with others, and GP and practice characteristics as significant influences in the adoption of new drugs, medical equipment and ICT in Irish general practices.
Conclusions:
This summary identifies possible levers for encouraging the adoption of health-care technologies by Irish GPs.
More Related Videos
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Dosage Regimens: Designs and Approaches
Dosage Regimen: Individualization
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Ethical Dilemmas II

